Analysis.

The article presents information on a research paper aimed at examining whether vitamin E supplements decrease the risk of cancer and cardiovascular events in patients at elevated cardiovascular risk. Vitamin E, as an antioxidant, may reduce mortality from both atherosclerotic cardiovascular disease and cancer. The paper was designed as a factorial trial in order to evaluate the effects of ramipril (10 mg per day) and vitamin E (400IU per day) both separately (in comparison with placebo) and in combination.